Showing 12 out of 2322 items
- This fact sheet examines education and employment as determinants of sexually transmitted and blood borne infection (STBBI) vulnerability among street-involved ...
- Breaks (fractures) in the bones that make up the spine are relatively common in people with osteoporosis. According to doctors in Milan, Italy, affected people ...
- The drug zoledronate (also known as zoledronic acid and sold under several brand names including Aclasta, Zometa and Reclast) is one of the drugs that doctors ...
- Researchers have found that when people initiate potent combination anti-HIV therapy (commonly called ART or HAART) their bones can lose some of their density. ...
- Osteoporosis Canada This organization has many helpful resources about bone health; below are just a few: Osteoporosis Canada Osteoporosis Canada’s guide ...
- Prevention in FocusAcross Canada, multidisciplinary care models are used to care for and treat people living with HIV and hepatitis C. A review of the scientific literature found that people living with HIV and/or…
- Chlamydia continues to be the most commonly reported sexually transmitted and blood borne infection in Canada. This resource synthesizes evidence, assesses the ...
- Sexually transmitted and blood borne infections continue to be a significant public health concern in Canada. Across Canada, infectious syphilis rates are on ...
- The Trans* Toolkit was designed for organizations striving to become more inclusive of their trans* clients, staff and ...
- The goal of this resource is to help community organizations, health professionals, educators and others to develop and implement evidence-informed STBBI ...
- Truvada is the name of a fixed-dose co-formulation of two anti-HIV drugs: tenofovir and FTC all in one pill.